featured
Efficacy of Dupilumab in Patients With Severe, Treatment-Refractory, and Fibrostenotic Eosinophilic Esophagitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world efficacy of dupilumab in severe, treatment-refractory, and fibrostenotic patients with eosinophilic esophagitis
Clin. Gastroenterol. Hepatol. 2023 Sep 01;[EPub Ahead of Print], CJ Lee, ES DellonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.